Introduction
Melanoma is a highly malignant tumor developing from transformed melanocytes or nevus cells. Its potential to metastasize early together with its weak responsiveness to chemotherapeutic drugs (Soengas and Lowe, 2003) results in mortality rates higher than for all other skin cancers together (Garbe and Blum, 2001) . Resistance to chemotherapy is often related to defects in apoptotic signaling cascades (Igney and Krammer, 2002; Guner et al., 2003) , but may be overcome by enhancement of proapoptotic pathways (Juin et al., 2004; Fischer and Schulze-Osthoff, 2005) .
Apoptosis has been defined as a genetic death program leading to the ordered destruction of cellular components, while membrane integrity is maintained. The balance between pro-and antiapoptotic signals guarantees biological homeostasis, and its disturbance is highly related to malignant transformation (Reed et al., 2004) . Two distinct major pathways have been described that lead to activation of aspartate-specific cysteine proteases (caspases) that finally mediate apoptosis. The extrinsic pathway involves binding of extracellular death ligands to specific cell surface death receptors and formation of the death-inducing signaling complex. The intrinsic pathway depends on mitochondria, is initiated by intracellular signals such as DNA damage and needs activation of the tumor suppressor p53 (Riedl and Shi, 2004) .
Key events of the mitochondrial pathway are permeabilization of the outer mitochondrial membrane and release of intermembrane cytochrome c into the cytosol, which results in activation of downstream caspases . Nevertheless, the mitochondrial pathway may also induce apoptosis in a caspase-independent manner (van Loo et al., 2002; Scholz et al., 2005) . The final result of most apoptosis cascades is cleavage of a variety of death substrates that are either activated upon cleavage or are inactivated and degraded (Fischer et al., 2003) .
The release of mitochondrial factors is controlled in a critical way at the level of the outer mitochondrial membrane by Bcl-2-related proteins. This large family segregates into anti-and proapoptotic factors, of which the proapoptotic subfamily further subdivides into multidomain proteins including Bax, Bak and Bok/ Mtd as well as into BH3-only proteins including natural born killer/Bcl-2 interacting killer (Nbk/Bik), Bid, Bad and others. BH3-only proteins are commonly regarded as specific death sensors, whereas the proapoptotic multidomain proteins act further downstream and control the release of proapoptotic factors and of mitochondrial permeability transition (Borner, 2003; Daniel et al., 2003) .
Basal expression of Nbk/Bik (Boyd et al., 1995; Han et al., 1996) in nonmalignant tissues was seen predominantly in epithelial and hematopoietic cells, suggesting a vital role for tissue-specific regulation of apoptosis (Daniel et al., 1999; Coultas et al., 2004) . Its expression is upregulated after DNA damage and can be triggered in a p53-dependent as well as in a p53-independent manner (Paquet et al., 2004) . Nbk/Bik activity may also be regulated by phosphorylation, which might be required for maximum proapoptotic activity (Verma et al., 2001) . So far, Nbk/Bik has been shown to trigger apoptosis in several tumor cell lines such as those from breast, lung, prostate and colon carcinoma as well as from glioma (Orth and Dixit, 1997; Tong et al., 2001; Germain et al., 2002; Radetzki et al., 2002; Gillissen et al., 2003; Naumann et al., 2003) . However, the activity of Nbk/Bik in melanoma cells, which display pronounced defects at the level of the mitochondrial apoptosis pathway (Raisova et al., 2000) , has not been investigated, and the mechanism of Nbk/Bik-induced apoptosis is still poorly understood.
The aim of the present investigation was to clarify the function of Nbk/Bik in regulation of apoptosis in melanoma cells. This was achieved by stable expression of Nbk/Bik applying an inducible expression system, and by monitoring its effects both in vitro and in melanoma xenotransplants. Our data demonstrate the high potential of Nbk/Bik for induction of apoptosis and inhibition of tumor growth in melanoma. Notably, and with regard to the apoptotic pathway, a clear independence of caspase activation was found.
Results

Weak expression of Nbk in melanoma cells and lack of expression in normal melanocytes
For obtaining an overview about the expression level of Nbk in melanoma cells as compared to normal human melanocytes (NHM), Northern blots were performed for 17 human melanoma cell lines and for three independent cultures of NHM. Nbk mRNA was identified in six of the melanoma cell lines: O-Mel-2 and SK-Mel-19 represented moderate basal expression levels while expression was weak in M-5, SK-Mel-28, Mel-HO and JPC-298, as compared to the colon carcinoma cell lines SW480 and Colo205 used as positive controls. Other melanoma cell lines as well as all NHM cultures, investigated, were negative for Nbk mRNA expression (Figure 1a) .
Western blot analysis was largely in agreement with the mRNA data. Expression of the 21 kDa Nbk protein was seen in both melanoma cell lines characterized by moderate Nbk mRNA expression (O-Mel-2, SK-Mel-19), whereas other melanoma cell lines and NHM cultures revealed only very weak expression or were negative (Figure 1b ).
Inducible overexpression of Nbk triggers apoptosis in melanoma cells
For investigating the effects of Nbk in regulation of melanoma cell apoptosis, Nbk cDNA was transfected and overexpressed conditionally in melanoma cell lines. Therefore, myc-tagged full-length cDNA of Nbk was subcloned into the tetracycline-regulatable expression plasmid pTRE-2, resulting in pTRE-Nbk. After transient transfection of pTRE-Nbk into tetracycline-regulatable melanoma cell lines, apoptosis was significantly induced Figure 1 Weak expression of Nbk in human melanoma cells. (a) Expression of Nbk mRNA (1000 nucleotides) as determined by Northern blotting was analysed for three cultures of normal human melanocytes (NHM) and for 17 human melanoma cell lines. As loading control, 18S ribosomal RNA as determined after ethidium bromide staining is shown below (2200 nucleotides). (Figure 2a ). After stable transfection of pTRE-Nbk in SKM13-Tet-On, three stably transfected cell clones were characterized (SKM13- . Doxycyclinetriggered expression of Nbk resulted in significant induction of apoptosis in all three clones. Strongest induction of apoptosis after 48 h in SKM13-Nbk-10 as compared to untreated mock-transfected cells coincided with highest inducibility of Nbk protein (Figure 2b ).
Typical morphological signs of apoptosis were observed in SKM13-Nbk-10, 48 and 96 h after doxycycline treatment, respectively. Chromatin condensation and nuclear shrinking was visualized by labeling cells with bisbenzimide. Quantification revealed a significant increase in numbers of nuclei with condensed DNA (35712%) after Nbk induction as compared to only 1076% seen in noninduced cells (Po0.001) and less than 4% seen in mock-transfected cells (Figure 3a) .
Labeling of free 3 0 -OH DNA termini via TUNEL staining revealed a similar picture, although, at a reduced level. After Nbk induction, 1274% of the cells were TUNEL-positive as compared to only 471% in noninduced cells (Po0.001) and 3% in mock-transfected cells (Figure 3b ). Further supporting these numbers, detection of cells with hypodiploid nuclei by FACS analysis (Nicoletti assay) revealed 15% hypodiploid cells after Nbk induction versus 6% in noninduced cells (data not shown).
DNA fragmentation was, in addition, visualized by a DNA ladder after subjecting total DNA to agarose gel electrophoresis (Figure 3c ). An SKM13-Tet-On cell clone stably transfected with pTRE-CD95L (SKM13-CD95L), described previously , was used as a positive control for the above experiments and showed largely comparable characteristics of apoptosis after induction of CD95L expression.
Monitoring time dependency of Nbk expression and of Nbk-induced apoptosis revealed conditional expression of the protein in SKM13-Nbk-10 cells as early as 6 h after addition of doxycycline, and expression levels further increased up to 48 h (Figure 4b ). Protein expression occured in parallel to continuously increasing DNA fragmentation up to 48 h, whereas LDH-release indicative for cytotoxicity was generally low at all times investigated (Figure 4a ).
The impact of Nbk expression on cell proliferation was determined by counting cell numbers up to day 12 past doxycycline treatment. After 12 days, cell numbers were decreased by 50% in doxycycline-treated SKM13-Nbk-10 cells compared to untreated controls (Figure 4c ), whereas proliferation in mock cells was unaffected by doxycycline treatment (Figure 4d ).
Nbk sensitizes melanoma cells for proapoptotic stimuli
To address the question of whether Nbk can overcome the distinct apoptosis resistance of melanoma cells, we treated SKM13-Nbk-10 cells with the chemotherapeutics etoposide (VP16; 0.3 mM), doxorubicin (Doxo; 0.2 mM) and pamidronate (Pam; 0.2 mM) as well as with the agonistic CD95 antibody CH-11 (0.5 mg/ml). Whereas mock-transfected cells were largely resistant to these treatments, induction of Nbk expression sensitized SK-Mel-13 cells for proapoptotic stimulation, resulting in significantly enhanced apoptosis, whereas LDH-release was largely unaffected ( Figure 5 ). 
Delayed melanoma growth in mice after Nbk induction
To investigate the potential of Nbk in preventing tumor growth in vivo, ten nude mice were subcutaneously injected with SKM13-Nbk-10 cells into both flanks, resulting in a total of 20 tumors. For promoter induction, five mice received doxycycline with the drinking water beginning with the day of tumor cell inoculation (day 1), whereas the control group of five animals did not receive doxycycline. Tumors became visible after 2-3 weeks at all injection sites, but melanoma growth was significantly delayed in doxycycline-treated animals, resulting in 45% smaller tumor volumes on day 47 than those in the control group (Po0.03; Figure 6 ). In contrast, doxycycline treatment had no effect on tumor growth in mice inoculated with mock-transfected cells (data not shown).
Nbk-induced apoptosis in melanoma cells is independent from caspase activation
To unravel the mechanism of Nbk-induced apoptosis in melanoma cells, involvement of caspases was investigated by the use of selective oligopeptide caspase inhibitors applied in increasing concentrations (10, 50 and 100 mM). SKM13-Nbk-10 cells as well as SKM13-CD95L cells used as positive control, were triggered with doxycycline for 48 h in the presence or absence of caspase inhibitors. Whereas CD95L-induced apoptosis was significantly reduced by inhibitors (50 and 100 mM) directed against caspase-3 (zDEVD-fmk), -4 (zYVADfmk), -8 (zIETD-fmk), -9 (zLEHD-fmk) and caspase-10-like proteases (zAEVD-fmk), these inhibitors did not affect Nbk-induced apoptosis. Only the pancaspase inhibitor zVAD-fmk, which is bound by a common functional motif of all caspases, completely blocked Nbk-induced apoptosis when applied in the 100 mM concentration. At the 50 mM concentration, apoptosis was inhibited by 4674%, whereas the 10 mM concentration was without effect. In clear contrast, CD95L-induced apoptosis was already completely blocked by 10 mM zVAD-fmk ( Figure 7) .
In parallel to these findings, Western blot analysis revealed, for doxycycline-induced SKM13-CD95L cells, increased processing of initiator caspase-8 to its active p18 subunit and of effector caspase-3 to its p17 and p20 products. In clear contrast, SKM13-Nbk-10 cells revealed no processing of these caspases at different times past doxycycline induction (6-48 h). Cleavage of caspase-6, -7 and -9 was seen only in Jurkat cells treated with the topoisomerase II inhibitor doxorubicin at 1 mM for 24 h, which were employed as positive controls (Figure 8a ).
For further proving that caspases were not involved in Nbk-induced apoptosis in melanoma cells, enzyme activity assays were performed for caspase-3, the main effector caspase. Again, caspase-3 activity was not found increased in doxycycline-induced SKM13-Nbk-10 cells (24 h) as compared to noninduced cells or mocktransfected cells. In clear contrast, effector caspase-3 was significantly activated in SKM13-CD95L cells after doxycycline induction (Po0.001, Figure 8b ). For investigating release of cytochrome c, a hallmark for activation of the mitochondrial apoptosis pathway, membrane fractions were separated from cytosolic fractions. After induction with doxycycline, Nbk protein appeared predominantly in the membrane and organelle fraction beginning after 6 h ( Figure 9) .
No increase of cytochrome c release or of AIF release into the cytosol was seen in SKM13-Nbk-10 cells at different times between 3 and 48 h after doxycycline induction. In contrast, cytochrome c and AIF release were clearly evident in these cells when they were treated for 24 h with 1 mM doxorubicin (Figure 9 ). Thus, Nbkinduced apoptosis in melanoma cells appeared as independent both from caspase activation and from cytochrome c release.
Discussion
Bcl-2-related proteins have been described as key regulators of the mitochondrial pathway to apoptosis. The BH3-only proapoptotic family members are triggers of the intrinsic apoptosis cascades as shown in various distantly related species such as nematodes (Egl-1 in Caenorhabditis elegans) and mammals (so far ten different BH3-only proteins identified in human). Expression of the BH3-only protein Nbk/Bik in untransformed mammalian tissue was found in hematopoietic cells such as activated B-and T-lymphocytes, in endothelial cells as well as in some epithelia including breast and kidney (Daniel et al., 1999; Jiang and Clark, 2001; Hur et al., 2004) . For human melanoma, expression of a number of proapoptotic Bcl-2 proteins such as, Bax, Bak, Bid and Bad has been reported (Hussein et al., 2003) , whereas others such as the BH3-only-like Bcl-x S were not found to be expressed at the protein level . For melanoma cells, we show here for the first time weak Nbk expression in a few cell lines whereas cultures of NHM were negative. These results are in agreement with previous findings showing upregulation of Nbk in human cancer cells, as from colon carcinoma, and from lymphoma as compared to the nonmalignant tissues (Daniel et al., 1999) . This may indicate a limited activation of apoptotic cascades by Nbk in some melanoma cell lines for which the execution of apoptosis appears to be blocked further downstream.
Basic expression of a proapoptotic Bcl-2 protein may cause resistance to the respective pathway. In agree- , were incubated for 48 h with doxycycline (black) or received different caspase inhibitors in addition to doxycycline (gray). Significant suppression of apoptosis as determined by the Student's t-test is marked by striped bars (Po0.05). Inhibitor concentrations were raised from 10 mM (top) to 50 mM (middle) and to 100 mM (bottom). Relative apoptosis values were calculated in relation to untreated cells, which were separately set to 1. Whereas pancaspase inhibitor zVAD-fmk is known to block all caspases, inhibitors C-1 to C-10 are described as specific for caspase-1 to caspase-10-like proteases and with pTRE-CD95L (CD95L), respectively. Nbk and CD95L expression was induced by applying doxycycline ( þ Dox) for 6, 12, 24 and 48 h, as indicated below. Equal amounts of proteins (50 mg/lane) were loaded and equal transfer of proteins was confirmed by ponceau red staining. Cleavage products described as catalytically active forms of caspase-8 (p18) and of caspase-3 (p17, p20) were seen in SKM13-CD95L cells after doxycycline induction, whereas cleavage of caspase-6, -7 and -9 was found only in positive controls (Jurkat cells treated with 1 mM doxorubicin for 24 h). As loading controls, b-actin Western blots are shown. (b) Enzymatic activity of caspase-3 was determined in extracts of SKM13-Nbk-10, SKM13-CD95L and mocktransfected cells, 24 h after induction with doxycycline ( þ Dox) and was compared to untreated cells (ÀDox). Caspase-3 substrate was added to the cell extracts and a time kinetics was established, of which here only the 2 h values are shown. Background activity in untreated mock cells (ÀDox) was set to 1. Means and standard deviations of three independent experiments, each consisting of double values, are given Nbk/Bik-induced apoptosis in melanoma M Oppermann et al
In the present study, we show for the first time that Nbk is a strong inducer of apoptosis in human melanoma cells, both after transient and after stable expression. Cell death induced by Nbk resulted from apoptosis as became clearly evident due to increase of mono-and oligonucleosomes, chromatin condensation, DNA strand breaks, hypodiploid cells and DNA fragmentation. The relative number of apoptotic cells after Nbk induction varied from 12% (DNA strand breaks, TUNEL) to 35% (chromatin condensation, bisbenzimide) indicative of the pronounced effect of Nbk on melanoma cells. The varying number of positive cells identified with different assays may be indicative of the special way that apoptosis is realized in melanoma cells.
Several molecular therapeutic approaches against cancer are targeted to overcome drug resistance, and are based on the combination with chemotherapeutic drugs. In this context, it has been reported that ectopic Nbk expression can overcome drug resistance in breast cancer and in lymphoma cells (Daniel et al., 1999; Radetzki et al., 2002) . In the present study, we found for melanoma cells, which are largely resistant to anticancer drugs, that conditional expression of Nbk can strongly enhance their sensitivity to chemotherapeutics as well as to CD95 ligation. Thus, triggering Nbk in melanoma may support the proapoptotic activities exerted by the immune system or those resulting from chemotherapies.
The antitumor activity of Nbk in melanoma was demonstrated in vivo in a human xenotransplant nude mouse model. Induction of Nbk resulted in significantly reduced tumor size and delayed tumor growth. Comparable results were also reported for xenotransplanted colon and prostate carcinoma, for which tumor formation could be prevented by intratumoral injection of Nbk adenovirus (Tong et al., 2001) .
Tremendous progress has been made in elucidating the molecular basis of apoptosis regulation through anti-and proapoptotic Bcl-2 proteins, but the mechanism of how BH3-only proteins trigger apoptosis is still largely elusive. The activity of BH3-only proteins, which connect death signals with the core apoptotic pathways, can be regulated by transcriptional expression as well as by post-translational modification. Their function is often discussed as upstream of the mitochondrial apoptosis pathway, and they have been shown to interact with several of the multidomain Bcl-2 proteins (Festjens et al., 2004) .
For Nbk, physical interaction with Bcl-2, Bcl-x L and adenoviral E1B-19K has been described via its BH3 domain (Boyd et al., 1995; Han et al., 1996; Tong et al., 2001) . Thereby, the antiapoptotic function of these factors was prevented and proapoptotic multidomain proteins such as Bax were enabled to undergo an N-terminal conformational switch and to insert into the outer mitochondrial membrane to promote apoptosis . However, heterodimerization with antiapoptotic proteins is not always a prerequisite for induction of apoptosis by Nbk, suggesting alternative apoptosis-promoting activities (Elangovan and Chinnadurai, 1997) . Also the finding that Nbk-induced apoptosis depends on Bax but not on Bak may be indicative of a direct effect of Nbk in apoptosis signaling .
The results of the present paper give clear indications for alternative apoptosis-promoting pathways, as Nbk-induced apoptosis in melanoma cells was neither associated with cleavage of common effector caspases nor with processing of caspase-9, the initiator caspase of the mitochondrial pathway. In addition, enzyme activity assays clearly showed increased activity of caspase-3, the main effector caspase in melanoma cells, after CD95L induction but not after Nbk induction.
Also no cytochrome c and AIF, which may induce apoptosis independent of caspases, were released from mitochondria after Nbk induction in melanoma cells. On the other hand, caspase activation was clearly evident in isogenic cells overexpressing the CD95 ligand, which were used here as control. These cells also release cytochrome c from mitochondria after induction of CD95L, as shown previously . Furthermore, CD95L-induced apoptosis, but not Nbkinduced apoptosis, was blocked by selective peptide inhibitors directed against caspase-3, -8 and -9. Thus, Figure 9 No mitochondrial release of proapoptotic factors after Nbk induction. Membrane fractions including organelles (M) and cytosolic fractions (C) were isolated from SKM13-Nbk-10 cells 3, 6, 12, 24 and 48 h after starting doxycycline treatment ( þ Dox) and were compared with untreated cultures (À). Nbk was identified predominantly in the membrane fraction starting with 6 h after doxycycline treatment. Proapoptotic mitochondrial intermembrane factors, cytochrome c and AIF, were not found in the cytosol at any time after Nbk induction. As positive control, SKM13-Nbk-10 cells treated for 24 h with doxorubicin (1 mM) were used (Doxo), showing significant release of cytochrome c and AIF as well as depletion in the mitochondrial fractions. VDAC and b-actin served as loading controls for membrane and cytosolic fractions, respectively Nbk/Bik-induced apoptosis in melanoma M Oppermann et al there was no indication for activation of the classical mitochondrial pathway in Nbk-induced apoptosis in melanoma cells. The novel caspase-and possibly mitochondriaindependent pathway of Nbk needs to be elucidated in future studies. Partial inhibition of Nbk-induced apoptosis by high concentrations of the pancaspase inhibitor zVAD-fmk found here for melanoma cells, may be indicative of the significance of other proteases, as zVAD-fmk has been found to inhibit other cysteine proteases such as cathepsins and calpains (Schotte et al., 1999; Bang et al., 2004; Fischer and Schulze-Osthoff, 2005) . For several of these proteases, a relation to apoptotic pathways has already been suggested (Foghsgaard et al., 2001; Broker et al., 2004) .
In line with a caspase-independent proapoptotic pathway, Nbk-induced apoptosis was also blocked by zVAD-fmk in glioma cells, whereas no caspase processing and no cytochrome c release were seen (Naumann et al., 2003) . In clear contrast, release of cytochrome c and activation of caspase-7 and -9 were reported for prostate and for colon carcinoma cells after Nbk induction (Tong et al., 2001; Gillissen et al., 2003) . These findings indicate that Nbk-mediated apoptosis operates through at least two distinct pathways, one caspasedependent and the other independent. Notably, the caspase-independent pathway seems to be of major significance for neuroectodermal cells (melanoma and glioma).
In summary, our data demonstrate that Nbk is a powerful inducer of apoptosis in melanoma cells. Conditional expression of Nbk enhanced the cytotoxic effects of chemotherapeutics and reduced melanoma growth in mice. Unraveling the specific pathways implicated in Nbk-induced apoptosis may finally allow the employment of this strong effector or a small molecule mimic in proapoptotic therapies for melanoma.
Materials and methods
Cell culture
NHM were isolated from human foreskin after trypsin digestion (Eisinger and Marko, 1982) and were cultivated serum-free as described (Eberle et al., 1999) . Four human melanoma cell lines were used for gene transfection: Bro (Lockshin et al., 1985) , Mel-2a (Bruggen et al., 1981) , SK-Mel-13 and SK-Mel-19 (Carey et al., 1976) . A reference list for other melanoma cell lines used for Northern blotting was given previously (Eberle et al., 1999) . Colon carcinoma cell lines SW480 and Colo205 were used as positive controls for Nbk expression (Suzuki et al., 2003) . Cell lines were maintained in DMEM (4.5 g/l glucose; Invitrogen, Karlsruhe, Germany) supplemented with 10% fetal calf serum and antibiotics (Biochrom AG, Berlin, Germany).
Chemotherapeutics were added to the growth medium 24 h before determination of DNA fragmentation and LDH release: etoposide (VP-16; Sigma-Aldrich, Taufkirchen, Germany; 0.3 mM), doxorubicin (QBiogene-Alexis, Gru¨nberg, Germany; 0.2 mM) and pamidronate (3-amino-1-hydroxypropylidene-1,1-bisphosphonate; Novartis Pharmaceuticals, Basel, Switzerland; 0.1 mM). The agonistic anti-CD95 antibody CH-11 (IgM mouse; Beckman Coulter, Krefeld, Germany) was applied for 16 h in a concentration of 0.5 mg/ml.
Conditional gene expression
The tetracycline-regulatable gene expression system had been described by Gossen and Bujard (1992) . SKM13-Tet-On, BroTet-On, Mel2a-Tet-Off and SKM19-Tet-Off cell lines were derived from melanoma cell lines SK-Mel-13, Bro, Mel-2a and SK-Mel-19 by stable transfection of pTet-On and pTet-Off plasmids, respectively (Clontech, Palo Alto, CA, USA). BroTet-On, SKM13-Tet-On and Mel2a-Tet-Off cell lines had already been described in previous papers (Eberle et al., 2002; Eberle et al., 2003) . For pTRE promoter activation (Tet-On cell lines) or repression (Tet-Off cell lines), 2 mg/ml doxycycline (ICN, Aurora, OH, USA) were added to the growth medium (Gossen and Bujard, 1992) . Doxycyline inducibility was quantified in SKM-19-Tet-Off cell clones after transient transfection of the luciferase-encoding plasmid pTRE-Luc (Clontech) followed by a luciferase assay (Promega, Madison, WI, USA) 48 h later, which revealed inducibility of gene expression of about 80-fold after doxycycline withdrawal.
Cell transfection
A human full-length cDNA fragment of fused to an N-terminal myc tag was inserted into the HindIII and XbaI restriction sites of the tetracycline-inducible vector pTRE-2 (Clontech), resulting in pTRE-Nbk.
Melanoma cells were seeded in six-well plates with 2 Â 10 5 cells/well. For transient transfection, cells at a confluence of 50% were washed with serum-free Opti-MEM medium (Invitrogen) followed by incubation with 0.1% DMRIE-C (Invitrogen) and 0.4 mg/ml pTRE-Nbk at 371C in Opti-MEM for 4 h. Double stably transfected cells were obtained by co-transfection of pTRE constructs and the hygromycin resistance plasmid pTK-Hyg (Clontech; 20 : 1 M ratio) into SKM13-Tet-On. Geneticin (Invitrogen; 400 mg/ml) and hygromycin (Boehringer, Mannheim, Germany; 100 mg/ml) were used for selection of transfected cells. Cell clones were obtained by limited dilution in microtiter plates and were continuously cultured in the presence of antibiotics. They were screened after transfection for protein overexpression by Western blot analysis. As controls, pTRE-2-transfected cell clones were generated from SKM13-Tet-On (mock). CD95L-transfected cells (SKM13-CD95L), used here as positive control, have been described previously (Fecker et al., 2005) .
Quantification of apoptosis and cytotoxicity
For promoter induction, cells were treated with doxycycline for 48 h immediately following transient transfection. Stably transfected cell clones were induced with doxycycline also for 48 h, starting at a cellular confluence of 50%. Apoptosis was quantified by using a cell death detection ELISA (Roche Diagnostics, Mannheim, Germany), which detects mono-and oligonucleosomes formed in apoptotic cells. Relative apoptotic rates were calculated as the ratio of ELISA values between doxycycline-induced and noninduced cells or by comparison to mock-transfected cells. Cytotoxicity was determined in parallel to apoptosis by a LDH-assay (Roche Diagnostics). Detailed protocols for apoptosis and cytotoxicity assays were described previously (Wieder et al., 1998) .
For visualization of apoptosis on a single-cell level, cells were stained by bisbenzimide. Cells were harvested by trypsinization, fixed in 4% formaldehyde (methanol-free) for 30 min at 41C and washed once with phosphate-buffered saline (PBS). Bisbenzimide (Hoechst-33258 dye, Sigma-Aldrich, 1 mg/ml), was added for 20 min at room temperature, and cells were washed again with PBS. Cells were mounted (MoBiTec, Go¨ttingen, Germany) and examined by fluorescence microscopy. Apoptotic cells were identified by condensed and shrunken nuclei. For quantification, a minimum of 500 cells each were counted, and the ratio of apoptotic cells was calculated as percent of total cells counted.
For analysing DNA strand breaks in individual cells, free 3 0 -OH termini were labelled by terminal deoxynucleotidyl transferase (TUNEL-reaction). Cells were harvested by trypsinization 96 h after induction with doxycycline. Cells were then fixed in 4% paraformaldehyde (1 h) and were permeabilized in a buffer containing 0.1% Triton-X-100 and 0.1% sodium citrate. TUNEL reaction mixture (Roche Diagnostics) was added for 1 h at 371C and cells were washed with PBS. Counterstaining was performed with Hoechst-33258 dye (Sigma-Aldrich, 1 mg/ml) added for 20 min at room temperature, after which cells were washed again with PBS. Cells were mounted (MoBiTec) and were analysed by fluorescence microscopy. Apoptotic cells were identified as bright green-stained nuclei. For quantification, a minimum of 700 cells each were counted, and the ratio of apoptotic cells was calculated as percent of total cell counts. Pictures of Hoechst-stained cells and TUNEL-stained cells determined at different wavelengths were finally overlayed.
Cell cycle analysis was performed by detection of hypodiploid nuclei in flow cytometric analyses (Nicoletti assay). Melanoma cells were induced with doxycycline for 96 h, harvested by trypsinization, stained with propidium iodide (200 mg/ml) and analysed by FACS (Nicoletti et al., 1991) .
For detection of a DNA ladder, cells were dissolved in lysis buffer (10 mM Tris, 1.0% SDS, 20 mM EDTA) followed by incubation for 5 min at 41C. Total genomic DNA was precipitated with isopropanol (50%) and resuspended DNA solutions were treated with RNaseA (2 mg/ml) for 10 min at 371C. Fragmented DNA was separated on 1.0% agarose gels and visualized by ethidium bromide staining.
For analysis of cell proliferation, cells were seeded in culture flasks (5 Â 10 4 cells/75 cm 2 flask). Doxycycline was added to the growth medium after 24 h and growth medium7doxycycline was changed every second day. For determination of cell numbers, one culture flask of each group was harvested every 48 h, and cells were counted.
Expression analyses for mRNA and protein
Total RNA was isolated from cell cultures during logarithmic growth phase (RNeasy; Qiagen, Hilden, Germany), 24 h after applying fresh growth medium. For Northern blotting, 30 mg of total RNA were separated per lane in formaldehyde/1.2% agarose gels. Blotting and hybridizations were carried out as described previously (Eberle et al., 1999) . As probe, a fulllength cDNA fragment of human Nbk was used, and signals were quantified by a BAS-1500 Phosphoimager (Fuji, Nakanuma, Japan). The ethidium bromide-stained 18S ribosomal RNA band served for normalization.
Total protein was extracted from cells harvested by trypsinization at a confluence of 60-80%. For analysis of Nbk and procaspase-3, cells were lysed in 10 mM Tris-HCl, pH 7.5, 150 mM NaCl, 1 mM EDTA, 2 mM PMSF, 1 mM leupeptin, 1 mM pepstatin, 0.5% SDS, 0.5% nonidet P-40. For analysis of caspase cleavage products, CHAPS cell extract buffer (Cell Signaling, Frankfurt, Germany) was used. For determination of cytochrome c and AIF release, cytosolic and mitochondrial proteins were fractionated by a mitochondria/cytosol fractionation kit (Alexis).
Cell lysates were homogenized and centrifuged for 5 min at 10 000 g. Each 50 mg was separated by electrophoresis under reducing conditions on 7-15% SDS-polyacrylamide gels in parallel with a broad range prestained SDS-PAGE protein standard (BioRad, Mu¨nchen, Germany). Proteins were transferred by electroblotting to Protran BA85 nitrocellulose membranes (Schleicher and Schu¨ll, Dassel, Germany). Blots were blocked overnight with PBS, 0.05% Tween, 5% nonfat dry milk and incubated with the respective antibodies diluted in blocking buffer. After washing with 0.05% Tween-20 in PBS, blots were incubated with peroxidase-labeled anti-rabbit, anti-goat or anti-mouse IgG (Dako, Hamburg, Germany) diluted 1 : 5000 in blocking buffer. After washing with PBS, 0.05% Tween-20, specific binding of antibodies was detected by chemiluminescence using ECL-Western blotting detection reagent (Amersham Pharmacia Biotech, Freiburg, Germany) on Hyperfilm ECL (Amersham Pharmacia Biotech).
The following antibodies were used: cleaved caspase-3: rabbit polyclonal IgG (#9661, 1 : 1000); caspase-6: rabbit polyclonal IgG (#9762, 1 : 1000); caspase-7: rabbit polyclonal IgG (#9492, 1 : 1000); caspase-8 1C12: mouse monoclonal IgG (#9746, 1 : 1000); caspase-9: rabbit polyclonal IgG (#9502, 1 : 1000), (Cell Signaling); Nbk/Bik: goat polyclonal IgG 
Analyses of caspase activity and inhibition of caspases
For caspase-3 activity assays, stably transfected cells were treated with doxycycline for 24 h or were left without. Cells were harvested by trypsinization and pelleted cells were lysed with cell lysis buffer (50 mM HEPES, pH 7.4, 0.1% CHAPS, 1 mM DTT, 0.1 mM EDTA, 0.1% Triton-X-100) to 2 Â 10 7 cells/ml. After centrifugation (10 000 g, 10 min), supernatants were treated with the chromatophor-labelled caspase-3 substrate in 96-well microtiter plates as described by the suppliers (Biomol International L.P., Butler Pike, PA, USA). For establishing a time kinetics, OD was measured in an ELISA reader every 30 min. Relative enzymatic activity rates were calculated as the ratio of ELISA values between doxycycline-induced and noninduced cells or by comparison to mock-transfected cells. As a further control, a caspase-3 inhibitor was applied to the cell lysates.
For apoptosis induction, cells received doxycycline for 48 h before apoptosis was determined. Irreversible caspase inhibitors (fluoromethyl ketone-(fmk)-derivatized oligopeptides) were applied simultaneously with doxycycline induction. They bind to the active site of caspase-like proteases and thereby inhibit their enzymatic activity: zVAD-fmk (pancaspase), zWEHD-fmk (caspase-1), zVDVAD-fmk (caspase-2), zDEVD-fmk (caspase-3), zYVAD-fmk (caspase-4), zVEIDfmk (caspase-6), zIETD-fmk (caspase-8), zLEHD-fmk (caspase-9), zAEVD-fmk (caspase-10) (all inhibitors from R&D Systems, Wiesbaden, Germany). Inhibitors were dissolved in DMSO at 100 mM and diluted with growth medium to final concentrations of 10, 50 and 100 mM.
Mouse experiments
Melanoma cells were harvested by brief incubation with trypsin/EDTA, followed by subsequent inactivation of trypsin by washing cells twice with growth medium containing 10% FCS. Before inoculation, cells were washed with PBS and were finally resuspended in PBS in a concentration of 10 6 cells/ 200 ml. Female, Balb C-nu/nu mice 6-8 weeks old (M&B A/S, Ry, Denmark) received s.c. injections of 10 6 cells (200 ml) into both flanks. For induction of the tetracycline-responsive promoter, animals received doxycycline with the drinking water (2 mg/ml enriched with 50 mg/ml sucrose), whereas control mice received only sucrose-enriched water. After tumors became visible, mice were seen twice a week, body weight was determined, and tumor size was measured. Animal experiments were performed according to the guidelines of the Federation of European Laboratory Animal Sciences Associations (FELASA).
Statistics
To demonstrate statistical significance for apoptosis and cytotoxicity assays as well as for tumor size in mouse experiments, the Student's t-test was applied.
